I hope so! But I can already tell they’re gonna pump Remdesivir and that steroid bullsht.
When it comes to MABs, Fauci and the NIH have already mentioned the names Regeneron and Eli Lilly during interviews as well as the other big boy names.
I’m still hopeful, you never know...
Could it be that the results for those initial 12 were cherry picked and that the rest of the trial is not going so well? Could explain the dead silence from the company.
Or perhaps they aren’t enrolling as fast as anticipated. For this phase they want patients at a very specific stage within the disease progression, so perhaps it’s taking a bit longer to enroll those specific types of patients?
Don’t know, just throwing my dark thoughts out there.
Kdog, you touched upon something very interesting, something I’ve often though about.
What if covid isn’t the main reason the big reputable names jumped into this oversubscribed pipe??
I’ve always thought that Lenz could be used in many different ways, and perhaps some that we haven’t even thought of yet. The Gilead Kite collaboration could be something with farther reaching potential than most may realize. Jmho.
If anyone is interested in the science behind GM-CSF and how Lenzilumab works then check out this doctor’s recent video.
I’m a visual learner and found it very useful in filling in some of my gaps of knowledge.
Lenzilumab - study shows positive results in seriously ill COVID-19 patients.https://t.co/x8Acg0fid5— Dr. Mobeen Syed (@drbeen_medical) July 23, 2020
Catalent just posted this:
Catalent expands contract with Humanigen Inc @humanigen to include full end-to-end services for COVID-19 MAb candidate. A Phase III study is currently underway evaluating hospitalized COVID-19 patients. Read the full article here: https://t.co/0p32VfKVpT @BioProcessIntl— Catalent Pharma (@CatalentPharma) July 20, 2020
I hope so. You could read between the lines a couple different ways, my reading and interpretation comes with more caution and reserve.
My concern recently seems to be that this company is having a hard time escaping the short lived ghosts of its past. That seems to have given them a ZERO margin for error. So hopefully there is some actual meat behind this PR.
Lenz and Humanigen mentioned in Bloomberg article. No actual detail as they chose to talk about the big boys.
Hard to tell the date, it seems pretty recent.
$MRNA's data no good - safety. This isn't about introducing a virus/flu shot. Messenger RNA delivered and the responses of immune system here clearly shows their platform is a non-starter. Immune system thinks it's a 'foreign invader. Want better #COVID19 modus? See $ALT & $VIR— H.Scott Matusow (@HScottMatusow) July 14, 2020
I see other companies tweet at the fda, that’s why they have twitter accounts. However, the companies that do mention them in their tweets have legitimate business with them. Honestly, I’m not too crazy about it either. It kind of comes off as the over eager little kid tugging on the bigger kids shirt asking “can i play too??”.
Lenzilumab, an engineered human IgG1 kappa monoclonal antibody, was associated with a clinical benefit in approximately one-third of patients with chronic myelomonocytic leukemia (#CMML) #leusm
Lenzilumab, an engineered human IgG1 kappa monoclonal antibody, was associated with a clinical benefit in approximately one-third of patients with chronic myelomonocytic leukemia (#CMML) #leusm https://t.co/gTN1FDOZkY— ASH Clinical News (@ASHClinicalNews) July 11, 2020
I agree, I’m not taking any more chances either. I took profit only once during that huge headfake back down to the low 2s. I’ll admit I got scared and sold, only to later buy my full position back in a little higher. I still did good because my initial purchases were in the .75-.95 range.
Long story short: I ain’t takin’ no more chances and do not plan on flipping again.
This told me everything I need to know and suspected about the online activity of their “investors”. What really got me suspicious is the amount of bashing they do on the various hgen boards around the Internet. Very telling sign to me. I think we don’t have much to worry about when it comes to that other company.
$CYDY pays 13 different stock promoters. You can see the list here:https://t.co/gx7s7tfUuJ— Adam Feuerstein (@adamfeuerstein) June 12, 2020
One of those stock promoters was paid by $CYDY to publish this today: https://t.co/Gm1SIJBn4p
Not much more needs to be said.